Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

13
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

17
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

38
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
38
Angina IV: Management01:26

Angina IV: Management

12
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

36
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

18
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke.

Polish archives of internal medicine·2026
Same author

Revisiting the ISCHEMIA trial data through non-linear machine learning modelling.

European journal of preventive cardiology·2026
Same author

Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences.

European heart journal·2026
Same author

CAPIRE score predicts long-term major cardiac events.

The international journal of cardiovascular imaging·2026
Same author

Transcatheter aortic valve thrombosis.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trial.

European journal of preventive cardiology·2026

関連する実験動画

Updated: Aug 1, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

789

冠動脈再血管化における現在の概念

Mario Gaudino1, Felicita Andreotti2, Takeshi Kimura3

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Lancet (London, England)
|April 30, 2023
PubMed
まとめ

冠動脈再血管化は外科的または皮膚経由の選択肢があります. 外科手術はリスクが高いですが 将来の心臓発作を減らすことができます 治療は患者によっては十分です

科学分野:

  • 心臓病科
  • 介入心臓科
  • 心臓外科

背景:

  • 冠動脈再血管化は,閉塞性冠動脈疾患の重要な治療法である.
  • 手術による再血管化は,皮膚経由の手術よりも高い手術リスクと長期の回復を伴う.
  • 心臓発作の再発を減らす効果があるにもかかわらず,現在のデータは主に特定の人口と地域を表しています.

研究 の 目的:

  • 冠動脈再血管化の現状を見直す
  • 手術と皮膚経由によるアプローチの比較リスクと利益を強調する.
  • 多様な患者集団とグローバルな文脈に関する既存の研究における重要なギャップを特定する.

主な方法:

  • 冠動脈再血管化に関する既存の文献のレビュー
  • 手術と皮膚経由の介入の結果の比較
  • 臨床的,解剖学的,好みに基づく要因を含む患者の選択基準の分析

主要な成果:

  • 手術による再血管化は,再発性心臓病の長期的減少をもたらすが,手術のリスクと回復時間がより高い.
  • 皮膚経由の治療は リスクが低く 回復が速い 代替手段です
  • 特定の患者のサブセットでは,治療のみが有効な選択肢である可能性があります.

さらに関連する動画

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.0K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.6K

関連する実験動画

Last Updated: Aug 1, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

789
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.0K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.6K
  • 現存する研究は 高所得国の白人男性に偏っています
  • 結論:

    • 患者の選択,臨床表現,および解剖学的要因が,再血管化の決定を導く.
    • 医療療法は治療の不可欠な要素であり,特定のケースでは十分かもしれません.
    • 女性,高齢者,少数民族,低所得から中所得国における再血管化の成果に関する包括的なデータは緊急に必要である.